GET THE APP
Ovarian Cancer Scientific Journals | Open Access Journals
Journal of Cancer Clinical Trials

Journal of Cancer Clinical Trials

ISSN: 2577-0535

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Ovarian Cancer Scientific Journals

The treatment of ovarian malignant growth has generally been recalcitrant, and required novel ways to deal with improve helpful productivity. This paper reports that thio-glucose bound gold nanoparticles (Glu-GNPs) can be utilized as a sensitizer to upgrade ovarian disease radiotherapy. The human ovarian malignant growth cells, SK-OV-3, were treated by gold nanoparticles (GNPs) alone, light alone, or GNPs notwithstanding illumination. Cell take-up was examined utilizing inductively coupled plasma nuclear emanation spectroscopy (ICP-AES), while cytotoxicity initiated by radiotherapy was estimated utilizing both 3-(4,5)- dimethylthiahiazo (- z-y1)- 3,5-di-phenytetrazoliumromide and clonogenic measures. The nearness of receptive oxygen species (ROS) was resolved utilizing CM-H2-DCFDA confocal microscopy and cell apoptosis was controlled by an Annexin V-FITC/propidium iodide (PI) unit with stream cytometry.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 95

Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report

Citation image
Journal of Cancer Clinical Trials peer review process verified at publons
Publon image

Indexed In

Related Links

 

Open Access Journals

arrow_upward arrow_upward